
Children’s Study Shows Evidence of COVID-19 and MIS-C Biomarker
PNL TEAM • September 27, 2021
PNL found that the biomarker, osteopontin, is elevated in patients with COVID-19 and MIS-C similarly to osteopontin levels in pediatric patients with TBIs and concussions.
The PNL team found that osteopontin was significantly elevated in patients with moderate and severe COVID-19 and MIS-C compared to mild or asymptomatic patients. Additionally, PNL found that osteopontin was correlated with clinical levels of COVID-19 severity while other biomarkers were not.
While larger follow-up trials are needed, PNL is hopeful that biomarkers can help determine the severity of COVID-19!
Check out the article here!

By PNL TEAM
•
March 12, 2026
Dr. Blackwell attended the inaugural meeting of the Paediatric Research for the Future of Children in Geneva, Switzerland. The forum has 5 main themes: Precision Medicine and Novel Therapies in Paediatrics, Big Data in Paediatric Research, Child Mental Health and Development, Early Life Determinants of Health and Disease, and Promoting Global Paediatric Research and Paediatric Clinician Scientists Dr. Blackwell presented Transforming Care for Pediatric Concussion: A Focus on Behavioral and Emotional Outcomes. She served as a speaker for the Child Mental Health and Development session alongside Dr. Constantino, Chief of Behavioral and Mental Health at CHOA.

By PNL TEAM
•
March 12, 2026
The Pediatric Neurocritical Care Research Group (PNCRG) focuses on advancing knowledge to optimize neurological outcomes in critically ill children by performing clinical and preclinical studies, supporting education, developing, and promoting best practices, and promoting advocacy. Dr. Reisner and Dr. Fainberg had the pleasure of presenting Biomarkers in Traumatic Brain Injuries in Children at a virtual meeting for PNCRG.

